Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Intraflagellar transport protein 81 homolog is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
IFT81 |
Gene ID: |
28981 |
Uniprot ID: |
IFT81_HUMAN |
Specificity: |
This antibody detects endogenous levels of IFT81 at Human, Mouse, Rat |
Immunogen: |
Synthesized peptide derived from human IFT81 |
Function | Component of the intraflagellar transport (IFT) complex B: together with IFT74, forms a tubulin-binding module that specifically mediates transport of tubulin within the cilium. Binds tubulin via its CH (calponin-homology)-like region. Required for ciliogenesis. Required for proper regulation of SHH signaling. Plays an important role during spermatogenesis by modulating the assembly and elongation of the sperm flagella. |
Protein Name | Intraflagellar Transport Protein 81 HomologCarnitine Deficiency-Associated Protein Expressed In Ventricle 1Cdv-1 |
Database Links | Reactome: R-HSA-5620924 |
Cellular Localisation | Cell ProjectionCiliumCytoplasm |
Alternative Antibody Names | Anti-Intraflagellar Transport Protein 81 Homolog antibodyAnti-Carnitine Deficiency-Associated Protein Expressed In Ventricle 1 antibodyAnti-Cdv-1 antibodyAnti-IFT81 antibodyAnti-CDV1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance